These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 834975
1. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Axelsson C, Jarnum S. Scand J Gastroenterol; 1977; 12(1):89-95. PubMed ID: 834975 [Abstract] [Full Text] [Related]
6. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU. Am J Gastroenterol; 2006 May 04; 101(5):1048-56. PubMed ID: 16573777 [Abstract] [Full Text] [Related]
7. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Folwaczny C, Wiebecke B, Loeschke K. Am J Gastroenterol; 1999 Jun 04; 94(6):1551-5. PubMed ID: 10364024 [Abstract] [Full Text] [Related]
8. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF. Am J Gastroenterol; 1998 Oct 04; 93(10):1860-6. PubMed ID: 9772045 [Abstract] [Full Text] [Related]
9. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Am J Gastroenterol; 2000 Mar 04; 95(3):677-83. PubMed ID: 10710056 [Abstract] [Full Text] [Related]
10. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. Glas J, Török HP, Daczo J, Tonenchi L, Folwaczny M, Folwaczny C. Eur J Med Res; 2005 Dec 07; 10(12):535-8. PubMed ID: 16356870 [Abstract] [Full Text] [Related]
11. [Therapeutic principles for chronic inflammatory bowel disease]. Binder V, Munkholm P. Ugeskr Laeger; 2001 Jan 01; 163(1):16-21. PubMed ID: 11586666 [Abstract] [Full Text] [Related]
12. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, Bretagne JF. Gastroenterol Clin Biol; 1997 Jan 01; 21(6-7):483-90. PubMed ID: 9295976 [Abstract] [Full Text] [Related]
13. [Surgical therapy of severe colitis]. Seelig MH, Uhlig H, Braun J, Schumpelick V. Chirurg; 1996 Feb 01; 67(2):150-4. PubMed ID: 8881212 [Abstract] [Full Text] [Related]
14. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis. Jarnum S, Jensen KB. Gastroenterology; 1975 Jun 01; 68(6):1433-44. PubMed ID: 1132626 [Abstract] [Full Text] [Related]
15. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Aliment Pharmacol Ther; 2004 Dec 01; 20(11-12):1347-52. PubMed ID: 15606397 [Abstract] [Full Text] [Related]
16. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM, Iser JH, Gibson PR. J Gastroenterol Hepatol; 2008 Jun 01; 23(6):954-8. PubMed ID: 17559377 [Abstract] [Full Text] [Related]
17. [Adjuvant therapy with elemental diet in chronic inflammatory intestinal diseases. Comparative study]. Rabast U, Heskamp R. Dtsch Med Wochenschr; 1986 Feb 21; 111(8):293-7. PubMed ID: 2868873 [Abstract] [Full Text] [Related]
18. [Emergency surgery in inflammatory bowel disease. Experience in 26 cases]. D'Addazio G, Scordamaglia R, Tedeschi U, Barra M, Arpe F, Beatini L, Meola V. Minerva Chir; 1998 Dec 21; 53(12):1001-7. PubMed ID: 10210930 [Abstract] [Full Text] [Related]
19. [Exclusive elemental enteral diet in cortico-resistant and cortico-dependent forms of Crohn's disease]. Le Quintrec Y, Cosnes J, Le Quintrec M, Contou JF, Baumer P, Bellanger J, Gendre JP. Gastroenterol Clin Biol; 1987 Dec 21; 11(6-7):477-82. PubMed ID: 3111930 [Abstract] [Full Text] [Related]
20. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group. Gut; 2008 Nov 21; 57(11):1518-23. PubMed ID: 18566104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]